The extraordinary general meeting in Soft-Ox Solutions AS was held Wednesday27 March 2024 . All agenda items were approved in line with the proposals in the extraordinary general meeting notice with the amendments set out in the notices from the Company earlier today. See separate press release with key information relating to the subsequent offering, with the following key information: Last day including right:27 March 2024 Ex-date:2 April 2024 Record date:3 April 2024 Date of approval:27 April 2024 Maximum number of new shares: 125,000,000 Subscription price:NOK 0,2 The Company will provide update on the subsequent offering in a separate notice. The minutes from the Extraordinary General Meeting in Norwegian and English are attached. For any questions or interview requests, please contact: Geir Almås, Chair ofSoftOx Solutions AS Mail: ir@soft-ox.com Phone: Geir Almås: (+47) 977 59 071 AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx) is aMedtech and pharmaceutical company listed on Euronext Growth Oslo under 'SOFTX'.SoftOx Solutions AS was founded in 2012 and is headquartered inOslo .The SoftOx Solutions Group includes: the holding companySoftOx Solutions AS , the Malmö subsidiary, and subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx is developing a highly effective antimicrobial solution for use in biofilm, viral and antimicrobial resistant infections. The patent-protected technology is based on extensive research and development in partnership with leading Nordic research institutes. For more information on SoftOx, visit www.soft-ox.com
Click here for more information
© Oslo Bors ASA, source